penicillin g has been researched along with sulbactam in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (29.03) | 18.7374 |
1990's | 3 (9.68) | 18.2507 |
2000's | 12 (38.71) | 29.6817 |
2010's | 7 (22.58) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Joyeau, R; Labia, R; Molines, H; Wakselman, M | 1 |
Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B | 1 |
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Arpin, C; Bezian, MC; Coulange, L; Demarthe, F; Dubois, V; Minarini, LA; Nordmann, P; Poirel, L; Quentin, C | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
Adinolfi, MF; Galli, R; Nichols, RL; Smith, JW; Vivoda, LM | 1 |
Bal, M; Panja, K; Ray, B | 1 |
Jones, RN | 1 |
Caine, VA; Foulds, G; Handsfield, HH | 1 |
Brenner, DG; Knowles, JR | 1 |
Yamabe, S | 1 |
Kemal, C; Knowles, JR | 1 |
Foulds, G; Hayes, SL; Marshall, DC; McMahon, FG; O'Brien, MM; Stankewich, JP; Weidler, DJ | 1 |
Fasching, CE; Fasola, EL; Peterson, LR | 1 |
Jansen, B; Perdreau-Remington, F; Pulverer, G | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Daschner, F; Schmidt-Eisenlohr, E; Wenzler, S | 1 |
Al-Nawas, B; Callaway, A; Geibel, MA; Karbach, J; Wagner, W; Willershausen, B | 1 |
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
Harrer, T; Schliep, S; Schuler, G; Simon, M; Tajmir-Riahi, A; Wörl, P | 1 |
2 trial(s) available for penicillin g and sulbactam
Article | Year |
---|---|
Inhibition of beta-lactamase-induced resistance in soft-tissue infections.
Topics: Abscess; Adolescent; Adult; Aged; Ampicillin; Bacteria; Bacterial Infections; beta-Lactamases; Cellulitis; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Penicillin G; Penicillin Resistance; Staphylococcal Infections; Sulbactam | 1985 |
Therapeutic trial and pharmacokinetics of sulbactam for uncomplicated gonorrhea in men.
Topics: Adolescent; Adult; beta-Lactamase Inhibitors; beta-Lactamases; Clinical Trials as Topic; Gonorrhea; Half-Life; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillanic Acid; Penicillin G; Sulbactam | 1984 |
29 other study(ies) available for penicillin g and sulbactam
Article | Year |
---|---|
N-aryl 3-halogenated azetidin-2-ones and benzocarbacephems, inhibitors of beta-lactamases.
Topics: Azetidines; Azetines; beta-Lactamase Inhibitors; Cephalosporins; Enzyme Inhibitors; Structure-Activity Relationship | 1988 |
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
Topics: Aged; Amino Acid Substitution; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Female; Genes, Bacterial; Humans; Isoelectric Point; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Recombinant Proteins | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
PER-6, an extended-spectrum beta-lactamase from Aeromonas allosaccharophila.
Topics: Aeromonas; Animals; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Paris; Water Microbiology | 2010 |
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin | 2010 |
Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoperazone; Ciprofloxacin; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Therapy, Combination; Female; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Peptostreptococcus; Prevotella melaninogenica; Rabbits; Sulbactam | 1990 |
Comparative in vitro inhibitory activities of novel beta-lactam compounds against multiresistant beta-lactamase producing Staphylococcus aureus.
Topics: beta-Lactamase Inhibitors; Clavulanic Acids; Drug Synergism; Penicillanic Acid; Penicillin G; Staphylococcus aureus; Sulbactam | 1986 |
In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Cell Membrane Permeability; Clavulanic Acids; Drug Interactions; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrolysis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Sulbactam | 1988 |
6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Binding, Competitive; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Hydrolysis; Isomerism; Kinetics; Penicillanic Acid; Penicillin G; Spectrophotometry, Ultraviolet; Sulbactam | 1984 |
Spectrophotometric determination of inhibitory effects of CP-45899 on beta-lactamase with benzylpenicillin and nitrocefin.
Topics: Bacillus cereus; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Cytochrome c Group; Hydrolysis; Oxidation-Reduction; Penicillanic Acid; Penicillin G; Spectrophotometry; Sulbactam | 1980 |
Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.
Topics: beta-Lactamase Inhibitors; Escherichia coli; Hydrogen-Ion Concentration; Kinetics; Penicillanic Acid; Penicillin G; Spectrophotometry, Ultraviolet; Sulbactam | 1981 |
Pharmacokinetics of sulbactam in humans.
Topics: Adult; Ampicillin; Cefoperazone; Cephalosporins; Drug Combinations; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Male; Penicillanic Acid; Penicillin G; Sulbactam | 1983 |
Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carrier Proteins; Cefoperazone; Female; Hexosyltransferases; Methicillin Resistance; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin-Binding Proteins; Peptidyl Transferases; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 1995 |
In-vitro activity of penicillin G plus sulbactam in comparison with other beta-lactamase inhibitor combinations and oxacillin against staphylococci.
Topics: beta-Lactamase Inhibitors; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Sulbactam | 1996 |
Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroidaceae Infections; beta-Lactams; Cefepime; Cefmetazole; Cefoperazone; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Lactams; Microbial Sensitivity Tests; Mouth Diseases; Penicillin G; Penicillins; Peptostreptococcus; Porphyromonas gingivalis; Prevotella; Streptococcal Infections; Streptococcus; Sulbactam | 2002 |
In vitro activity of penicillin G/sulbactam compared with penicillin and other antibiotics against common organisms causing ear, nose and throat (ENT) infections.
Topics: Bacterial Infections; Drug Therapy, Combination; Humans; Otorhinolaryngologic Diseases; Penicillin G; Penicillins; Sulbactam | 2003 |
Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Bacteria, Anaerobic; Dental Implants; Dental Plaque; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Gram-Positive Rods; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G; Quinolines; Sulbactam | 2007 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
Life-Threatening Atypical Case of Acute Generalized Exanthematous Pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecium; Humans; Male; Penicillin G; Periodontitis; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Systemic Inflammatory Response Syndrome | 2017 |